HBM contact: Dr Ivo Staijen, Dr Chandra P. Leo
Company status: public
Longboard Pharmaceuticals aims to deliver novel,
transformational medicines to patients with rare neurological diseases,
including developmental and epileptic encephalopathies. Longboard's compounds
were discovered and evolved out of the validated world-class GPCR research
engine of Arena Pharmaceuticals.